127801-02-9

Basic information

• Product Name: 5-(4-hydroxyphenyl)-10,15,20-tris(pyridin-4-yl)porphyrin
• Synonyms: 5-(4-hydroxyphenyl)-10,15,20-tris(pyridin-4-yl)porphyrin
• CAS NO: 127801-02-9
• Molecular Weight: 633.712
• Mol File: 127801-02-9.mol
• Article Data: 14

Chemical Properties

• CAS DataBase Reference: 5-(4-hydroxyphenyl)-10,15,20-tris(pyridin-4-yl)porphyrin(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4-hydroxyphenyl)-10,15,20-tris(pyridin-4-yl)porphyrin(127801-02-9)
• EPA Substance Registry System: 5-(4-hydroxyphenyl)-10,15,20-tris(pyridin-4-yl)porphyrin(127801-02-9)

Safety Data

• Hazardous Substances Data: 127801-02-9(Hazardous Substances Data)

Upstream product

• 872-85-5 pyridine-4-carbaldehyde 
• 109-97-7 pyrrole 
• 123-08-0 4-hydroxy-benzaldehyde 
• 139547-50-5 5-(4-methoxyphenyl)-10,15,20-tris(4-pyridyl)porphyrin 
• 26725-51-9 4-hydroxybenzotriazole 
• 139547-50-5 5-(4-methoxyphenyl)-10,15,20-tri(N-methylpyridinium-4-yl)porphyrin triiodide 

Relevant articles and documents

Synthesis of Cationic Metalloporphyrin Precursors Related to the Design of DNA Cleavers

-

Mitochondria-targeting Pt/Mn porphyrins as efficient photosensitizers for magnetic resonance imaging and photodynamic therapy

Photodynamic therapy (PDT), as a minimally invasive and highly efficient anticancer approach, has received extensive attention. However, the search for more effective and less toxic photodynamic photosensitizers with good biocompatibility and high specifi

Water-soluble porphyrin-phosphonate conjugates as potential photodynamic therapy photosensitizers

Two novel water-soluble porphyrin-phosphonate conjugates were synthesized and characterized. Although both conjugates showed significant potential in photodynamic therapy, the variety of their structure induced the obvious differences in the binding manne

The synthesis and photodynamic properties of meso-substituted, cationic porphyrin derivatives in HeLa cells

A series of asymmetric porphyrins with varying substituents, such as 4-hydrophenyl and N-methyl-4-pyridyl, were synthesized and characterized and their cell uptake, intracellular localization, cytotoxicities and phototoxicities were evaluated in vitro. The most phototoxic of the porphyrins synthesized, 5,10-di-(N-methyl-4-pyridyl)-15,20-(4-hydroxyphenyl)-21,23H-porphyrin, which was mainly localized in the mitochondria and displayed low levels of dark toxicity toward human cancer HeLa cells, offers potential application in photodynamic therapy.